HEA BeadChip™ technology in immunohematology

Cinzia Paccapelo, Francesca Truglio, Maria Antonietta Villa, Nicoletta Revelli, Maurizio Marconi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Classic methods to determine human red blood cell (RBC) antigens are based on serologic testing. Thanks to increased knowledge of the molecular basis associated with many blood group antigens, it is currently possible to predict their presence or absence on the red cell membrane. Several molecular techniques have been developed to detect the most important allelic variations attributable to single nucleotide polymorphisms. The human erythrocyte antigen (HEA) BeadChip™ system manufactured by BioArray Solutions (Immucor, Warren, NJ) is one of the commercial DNA array platforms currently available to predict HEAs by DNA analysis. This technology provides a useful tool to increase the inventory of antigen-negative RBC units and prevent immunization of patients who require chronic transfusion by providing compatible RBC units based on matching by DNA testing.

Original languageEnglish
Pages (from-to)81-90
Number of pages10
JournalImmunohematology
Volume31
Issue number2
Publication statusPublished - 2015

Fingerprint

Erythrocytes
Technology
Antigens
DNA
Blood Group Antigens
Oligonucleotide Array Sequence Analysis
Single Nucleotide Polymorphism
Immunization
Cell Membrane
Equipment and Supplies

ASJC Scopus subject areas

  • Immunology and Allergy
  • Medicine(all)
  • Hematology

Cite this

Paccapelo, C., Truglio, F., Antonietta Villa, M., Revelli, N., & Marconi, M. (2015). HEA BeadChip™ technology in immunohematology. Immunohematology, 31(2), 81-90.

HEA BeadChip™ technology in immunohematology. / Paccapelo, Cinzia; Truglio, Francesca; Antonietta Villa, Maria; Revelli, Nicoletta; Marconi, Maurizio.

In: Immunohematology, Vol. 31, No. 2, 2015, p. 81-90.

Research output: Contribution to journalArticle

Paccapelo, C, Truglio, F, Antonietta Villa, M, Revelli, N & Marconi, M 2015, 'HEA BeadChip™ technology in immunohematology', Immunohematology, vol. 31, no. 2, pp. 81-90.
Paccapelo, Cinzia ; Truglio, Francesca ; Antonietta Villa, Maria ; Revelli, Nicoletta ; Marconi, Maurizio. / HEA BeadChip™ technology in immunohematology. In: Immunohematology. 2015 ; Vol. 31, No. 2. pp. 81-90.
@article{20a7d991d8384764b2ad4bea8863e8d3,
title = "HEA BeadChip™ technology in immunohematology",
abstract = "Classic methods to determine human red blood cell (RBC) antigens are based on serologic testing. Thanks to increased knowledge of the molecular basis associated with many blood group antigens, it is currently possible to predict their presence or absence on the red cell membrane. Several molecular techniques have been developed to detect the most important allelic variations attributable to single nucleotide polymorphisms. The human erythrocyte antigen (HEA) BeadChip™ system manufactured by BioArray Solutions (Immucor, Warren, NJ) is one of the commercial DNA array platforms currently available to predict HEAs by DNA analysis. This technology provides a useful tool to increase the inventory of antigen-negative RBC units and prevent immunization of patients who require chronic transfusion by providing compatible RBC units based on matching by DNA testing.",
author = "Cinzia Paccapelo and Francesca Truglio and {Antonietta Villa}, Maria and Nicoletta Revelli and Maurizio Marconi",
year = "2015",
language = "English",
volume = "31",
pages = "81--90",
journal = "Immunohematology",
issn = "0894-203X",
publisher = "American Red Cross",
number = "2",

}

TY - JOUR

T1 - HEA BeadChip™ technology in immunohematology

AU - Paccapelo, Cinzia

AU - Truglio, Francesca

AU - Antonietta Villa, Maria

AU - Revelli, Nicoletta

AU - Marconi, Maurizio

PY - 2015

Y1 - 2015

N2 - Classic methods to determine human red blood cell (RBC) antigens are based on serologic testing. Thanks to increased knowledge of the molecular basis associated with many blood group antigens, it is currently possible to predict their presence or absence on the red cell membrane. Several molecular techniques have been developed to detect the most important allelic variations attributable to single nucleotide polymorphisms. The human erythrocyte antigen (HEA) BeadChip™ system manufactured by BioArray Solutions (Immucor, Warren, NJ) is one of the commercial DNA array platforms currently available to predict HEAs by DNA analysis. This technology provides a useful tool to increase the inventory of antigen-negative RBC units and prevent immunization of patients who require chronic transfusion by providing compatible RBC units based on matching by DNA testing.

AB - Classic methods to determine human red blood cell (RBC) antigens are based on serologic testing. Thanks to increased knowledge of the molecular basis associated with many blood group antigens, it is currently possible to predict their presence or absence on the red cell membrane. Several molecular techniques have been developed to detect the most important allelic variations attributable to single nucleotide polymorphisms. The human erythrocyte antigen (HEA) BeadChip™ system manufactured by BioArray Solutions (Immucor, Warren, NJ) is one of the commercial DNA array platforms currently available to predict HEAs by DNA analysis. This technology provides a useful tool to increase the inventory of antigen-negative RBC units and prevent immunization of patients who require chronic transfusion by providing compatible RBC units based on matching by DNA testing.

UR - http://www.scopus.com/inward/record.url?scp=84982985653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982985653&partnerID=8YFLogxK

M3 - Article

C2 - 26495894

AN - SCOPUS:84982985653

VL - 31

SP - 81

EP - 90

JO - Immunohematology

JF - Immunohematology

SN - 0894-203X

IS - 2

ER -